Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)
Recruiting
Phase 2
Interventional Study
Postoperative Analgesia After Unilateral Hip Arthroplasty
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 200 (estimated)
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a phase IIa, multicenter ,randomized, double-blind, Double-Dummy, Active- and placebo-controlled study designed to evaluate the efficacy, safety and kinetic characteristics of TRD205 tablets for postoperative analgesia after unilateral hip arthroplasty
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Able to provide written informed consent
* Age 18 to 80 years, inclusive
* BMI 18-32 kg/m²
* ASA physical status I-II
* Scheduled for elective unilateral total hip arthroplasty under general anesthesia
* Able to understand study procedures and pain rating scales
Exclusion Cri…
Contacts
xiaohong zhang Beijing Tide Pharmaceutical Co., Ltd
86-10-6788-0648-5064
CONTACT